Camlin Fine Sciences Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Results
Camlin Fine Sciences share price Rs 100.88 on 17 September 2026, up 2.81%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 34.00 crore loss. Q2 FY26 base a loss of Rs 15.00 crore.
Quick Answer
The Camlin Fine Sciences Q2 results date for FY27 is not confirmed, and Camlin Fine Sciences Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 460.00 crore in revenue and a loss of Rs 15.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Camlin Fine Sciences Q2 results FY27 announcement is the next scheduled earnings event for Camlin Fine Sciences Ltd., Camlin Fine Sciences Ltd manufactures speciality chemicals and food antioxidants, including vanillin and blended preservative solutions used by the food, feed and industrial sectors.. The stock traded at Rs 100.88 on the NSE on 17 September 2026, up 2.81% from the previous close of Rs 98.12, about 57.1% below its 52-week high of Rs 235.00 and 4.9% above its 52-week low of Rs 96.21.
What makes the Camlin Fine Sciences Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 460.00 crore of revenue and a loss of Rs 15.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 520.00 crore and a loss of Rs 34.00 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Camlin Fine Sciences Q2 Results FY27 Date?
The Camlin Fine Sciences Q2 results date for FY27 is not confirmed. As of 17 September 2026, Camlin Fine Sciences Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
Also read – Nazara Technologies Q2 Results FY27 Preview: Results Date, Expectations
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Camlin Fine Sciences Q2 results date becomes public through that filing rather than through any advance announcement.
The Camlin Fine Sciences Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Camlin Fine Sciences.
Camlin Fine Sciences Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Camlin Fine Sciences Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Camlin Fine Sciences. The Camlin Fine Sciences Q2 results watchlist below is built from what the company has actually reported and disclosed.
Ahead of the Camlin Fine Sciences Q2 results for the September 2026 quarter, the company’s recent profit history is the first thing worth understanding. Net profit has swung between losses of Rs 11 crore, Rs 15 crore and Rs 37 crore in the June 2025, September 2025 and December 2025 quarters respectively, before a sharp Rs 86 crore profit in March 2026 and a return to a Rs 34 crore loss in the June 2026 quarter. Revenue over the same period has been comparatively steadier, moving from Rs 408 crore to Rs 460 crore, Rs 441 crore, Rs 425 crore and Rs 520 crore across those five quarters. Given that the March 2026 profit stands out sharply against four loss-making quarters, it looks like a one-off or exceptional item rather than a new normal, and that context matters for anyone reading the Camlin Fine Sciences Q2 results.
Operating margin has stayed in a narrow single-digit band across recent quarters, from about 5.0% in June 2025 and 7% in September 2025 down to 1.8% in the June 2026 quarter, reflecting pressure on profitability even before the impact of other expenses and one-off items further down the income statement. Return on equity of 3.75% and return on capital employed of 4.78% are both modest, consistent with a company that has struggled to convert revenue into consistent bottom-line profit. The speciality chemicals sector in India has faced input cost pressure and demand fluctuations through 2025 and 2026, and Camlin Fine Sciences appears to be facing more difficulty in that environment than some peers, a factor that will weigh on how the Camlin Fine Sciences Q2 results are received.
Also read – Premier Energies Q2 Results FY27 Preview: Results Date, Expectations
As the Camlin Fine Sciences Q2 results for the September 2026 quarter come into view, the honest picture is one of a company whose profitability has been inconsistent, with four loss-making quarters out of the last five and only one clear profit that looks more like an exception than a trend. With price to earnings not meaningful given the trailing loss position, a book value of Rs 54.2 and a dividend yield of zero, the stock’s valuation reflects that uncertainty. Anyone tracking the Camlin Fine Sciences Q2 results would be well served by watching whether the company can post a second consecutive profitable quarter, which it has not managed in the recent past.
Check Camlin Fine Sciences Ltd. Live Fundamentals on the Univest Screener
Camlin Fine Sciences Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Camlin Fine Sciences Ltd. reported revenue of Rs 520.00 crore in Q1 FY27, up 27.45% from Rs 408.00 crore in Q1 FY26, and a loss of Rs 34.00 crore at the net level, a wider loss than the Rs 11.00 crore loss of Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was up 22.35% over the March 2026 quarter figure of Rs 425.00 crore, and net profit was a swing from a profit of Rs 86.00 crore in Q4 FY26 to a loss of Rs 34.00 crore. Operating margin stood at 5.0% in Q1 FY27 against 7.0% in the September 2025 quarter, which is the comparison the Camlin Fine Sciences Q2 results print will be read against.
Q2 FY26 Base: The Comparison Camlin Fine Sciences Q2 Results FY27 Must Beat
Camlin Fine Sciences Ltd. reported revenue of Rs 460.00 crore and a loss of Rs 15.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Camlin Fine Sciences Q2 results preview.
Because the base quarter itself was loss-making, a year-on-year percentage comparison of profit is not meaningful for Camlin Fine Sciences. The more useful test in the Camlin Fine Sciences Q2 results print is whether the company reports a profit at all, and how the income line of Rs 460.00 crore compares with the Rs 520.00 crore of the June 2026 quarter.
Camlin Fine Sciences Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 460.00 | (15.00) |
| Q3 FY26 (Dec 2025) | 441.00 | (37.00) |
| Q4 FY26 (Mar 2026) | 425.00 | 86.00 |
| Q1 FY27 (Jun 2026) | 520.00 | (34.00) |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Camlin Fine Sciences Q2 results preview uses.
Revenue across those four quarters ranged from Rs 425.00 crore to Rs 520.00 crore, and net profit from Rs 37.00 crore loss to Rs 86.00 crore. That spread is the honest context for the Camlin Fine Sciences Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Camlin Fine Sciences Q2 Results FY27
The Camlin Fine Sciences Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Camlin Fine Sciences has already reported.
A History Of Losses With One Outlier
Four of the last five quarters have ended in a net loss for Camlin Fine Sciences, with only the March 2026 quarter’s Rs 86 crore profit breaking that pattern, and that figure appears tied to a one-off or exceptional item rather than a repeatable improvement in the core business. This history is the central factor to weigh ahead of the Camlin Fine Sciences Q2 results.
Thin And Volatile Margins
Operating margin has moved between roughly 1.8% and 7% over the last five quarters, a narrow and unstable range that suggests limited pricing power or cost control in the underlying chemicals business. A margin recovery, if any is seen in the upcoming numbers, would be an important signal for how the Camlin Fine Sciences Q2 results are interpreted.
Balance Sheet And Valuation Signals
A debt to equity ratio of 0.69 and return on equity of under 4% point to a balance sheet that is manageable but a return profile that remains weak, and with price to earnings not meaningful on trailing losses, the market appears to be pricing in continued uncertainty rather than a rebound. These are the metrics worth revisiting once the Camlin Fine Sciences Q2 results are out.
Camlin Fine Sciences Q2 Results FY27: Share Price and Valuation Going Into the Print
Camlin Fine Sciences share price today is Rs 100.88 on the NSE, up Rs 2.76 or 2.81% from the previous close of Rs 98.12 on 17 September 2026, ahead of the Camlin Fine Sciences Q2 results announcement.
| Metric | Value (17 September 2026) |
|---|---|
| NSE Symbol | CAMLINFINE |
| Current Market Price | Rs 100.88 |
| 52-Week High | Rs 235.00 |
| 52-Week Low | Rs 96.21 |
| Market Capitalisation | Rs 1932 crore |
| PE Ratio | Not meaningful on a trailing loss |
| PB Ratio | 1.86 |
| EPS (TTM) | Not meaningful on a trailing loss |
| Book Value per Share | Rs 54.20 |
| Debt to Equity | 0.69 |
| Return on Equity | 3.75% |
| 50-Day Moving Average | Rs 121.72 |
| 200-Day Moving Average | Rs 155.73 |
| RSI (14) | 43.83 |
The stock trades below both its 50-day average of Rs 121.72 and its 200-day average of Rs 155.73, with a 14-day RSI of 43.83. None of this is a view on where the shares go once the Camlin Fine Sciences Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Camlin Fine Sciences Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Camlin Fine Sciences Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Camlin Fine Sciences Q2 results print in proportion.
- Revenue against the Rs 460.00 crore reported in the September 2025 base quarter
- Net profit against a loss of Rs 15.00 crore in that same quarter
- Operating margin against 5.0% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Camlin Fine Sciences Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Camlin Fine Sciences Q2 Results FY27
The Camlin Fine Sciences Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Camlin Fine Sciences Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Camlin Fine Sciences Q2 results FY27 print faces a base of Rs 460.00 crore in revenue and a loss of Rs 15.00 crore, with the most recent quarter having delivered Rs 520.00 crore and a loss of Rs 34.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Camlin Fine Sciences, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Camlin Fine Sciences Q2 Results FY27
What is the Camlin Fine Sciences Q2 results date for FY27?
Ans. The Camlin Fine Sciences Q2 results date for FY27 is not confirmed. Camlin Fine Sciences Ltd. had not filed a board meeting intimation with the NSE or BSE as of 17 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Camlin Fine Sciences Q2 results 2026 cover?
Ans. The Camlin Fine Sciences Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Camlin Fine Sciences Ltd. reports revenue, operating profit and net profit for that period, and the Camlin Fine Sciences Q2 results filing also carries the notes to the accounts.
What were the Camlin Fine Sciences Q1 FY27 results?
Ans. Camlin Fine Sciences Ltd. reported revenue of Rs 520.00 crore in Q1 FY27 and a loss of Rs 34.00 crore at the net level. Revenue was up 27.45% versus Q1 FY26 and net profit was a wider loss than the Rs 11.00 crore loss of Q1 FY26.
What were Camlin Fine Sciences Q2 FY26 results in the September 2025 quarter?
Ans. Camlin Fine Sciences Ltd. reported revenue of Rs 460.00 crore and a loss of Rs 15.00 crore in Q2 FY26. Operating margin was 7.0%. Those figures form the base for the Camlin Fine Sciences Q2 results FY27 comparison.
What are the main Camlin Fine Sciences Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Camlin Fine Sciences Q2 results expectations centre on revenue against the Rs 460.00 crore base, net profit against a loss of Rs 15.00 crore, operating margin against 5.0% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Camlin Fine Sciences share price today ahead of the Q2 earnings?
Ans. Camlin Fine Sciences share price is Rs 100.88 on the NSE as of 17 September 2026, up 2.81% from Rs 98.12. The stock is about 57.1% below its 52-week high of Rs 235.00 and 4.9% above its 52-week low of Rs 96.21, at a market capitalisation of Rs 1932 crore.
Is Camlin Fine Sciences a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Camlin Fine Sciences Ltd. The stock trades at a price-to-book ratio of 1.86 with a return on equity of 3.75%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
